The AI solution your company just implemented finished its task in minutes. The review, however, is still waiting for someone with time to do it. For clinical teams introducing AI into data review, document development, and trial planning, that gap can determine whether a faster output actually produces any meaningful time savings.
Put simply , human review can become the bottleneck when AI generates more work than qualified experts can assess. Avoiding that bottleneck requires attention to what reaches reviewers, how easily they can verify it, and which decisions deserve their closest scrutiny. Those choices belong in the workflow before deployment.
Measure the time to a usable result
Drafting speed is easy to demonstrate. The work that follows is less visible: finding source material, checking assumptions, correcting errors, resolving disagreements, and approving the result.
Consider an AI-generated clinical data query. A clear, relevant draft with the supporting records readily available may save a reviewer time. A polished draft that duplicates an existing query or leaves its rationale unclear creates another investigation. Once sent, an unnecessary query also consumes site capacity.
The useful comparison therefore includes the complete process, from identifying a need to reaching an accepted result. A faster first draft matters when the work around it also becomes easier.
Make the evidence easy to inspect
Review becomes expensive when experts have to reconstruct how an output was produced. A recommendation may sound reasonable, but assessing it requires knowing which information it used, whether that information is current, and where interpretation entered the process.
For clinical AI, a useful review package should make three things readily accessible:
The supporting evidence: relevant records, document sections, or analytical code.
The assumptions and gaps: missing information, unresolved discrepancies, and limitations that could affect the result.
The decision required: what the reviewer must confirm, change, reject, or escalate.
This is a practical design requirement. Placing a recommendation beside its supporting evidence reduces the effort spent navigating systems and gives reviewers more time to evaluate its clinical or operational meaning.
Match review effort to the consequences
A draft administrative message and an analysis informing a consequential study decision call for different scrutiny. Applying the same review process to both can waste expert capacity while obscuring where careful judgment matters most.
Teams should define review requirements around intended use, potential consequences, and demonstrated system performance. Automated checks can address problems such as missing required information, duplicate content, or inconsistent formatting before an output reaches a person. Clinical interpretation and consequential decisions still need appropriately qualified judgment.
Confidence scores and consistent outputs require care, too. An answer that appears repeatedly may still be wrong. Evidence about reliability should inform review priorities alongside the underlying sources and the significance of the decision.
Test the reviewers’ workload during the pilot
A pilot should reveal whether the proposed review process works under realistic conditions. That means involving the people who will own the work and testing incomplete inputs, ambiguous cases, and competing demands on their time.
Useful measures include:
Total time to an accepted output, including waiting and rework.
The proportion of outputs requiring substantive correction.
The age and size of the review backlog.
Problems discovered after approval or passed downstream.
Interpret these measures together. A high approval rate might indicate strong performance, but it could also reflect insufficient scrutiny. Short review times are encouraging only when the resulting quality holds up.
Testing the workflow also makes responsibilities concrete. Reviewers need to know what they own, what evidence supports their decision, and where to take an issue they cannot resolve.
Give expert attention a budget
Generating another output is easy. Finding another hour of experienced clinical judgment is harder. Before expanding an AI workflow, teams should establish whether they are reducing the effort needed for a useful result or simply increasing the volume awaiting approval.
That makes review capacity part of the business case for clinical AI. The strongest implementations will give experts fewer avoidable checks, clearer evidence, and more time for decisions that warrant their attention.
Continue the conversation at SCOPE Summit, March 1–4, 2027, in Orlando, Florida. Join colleagues across clinical research to explore AI, clinical data strategy, and practical approaches to improving trial execution. Explore the program and register.